- Home
- CENX vs ARDX Comparison
CENX vs ARDX Comparison
Compare CENX & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENX
- ARDX
- Stock Information
- Founded
- CENX 1995
- ARDX 2007
- Country
- CENX United States
- ARDX United States
- Employees
- CENX N/A
- ARDX N/A
- Industry
- CENX Aluminum
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- CENX Industrials
- ARDX Health Care
- Exchange
- CENX Nasdaq
- ARDX Nasdaq
- Market Cap
- CENX 1.5B
- ARDX 1.3B
- IPO Year
- CENX 1996
- ARDX 2014
- Fundamental
- Price
- CENX $15.88
- ARDX $3.62
- Analyst Decision
- CENX Strong Buy
- ARDX Strong Buy
- Analyst Count
- CENX 3
- ARDX 8
- Target Price
- CENX $23.00
- ARDX $10.19
- AVG Volume (30 Days)
- CENX 1.5M
- ARDX 6.3M
- Earning Date
- CENX 05-07-2025
- ARDX 05-01-2025
- Dividend Yield
- CENX N/A
- ARDX N/A
- EPS Growth
- CENX 35.22
- ARDX N/A
- EPS
- CENX 3.12
- ARDX N/A
- Revenue
- CENX $2,223,300,000.00
- ARDX $361,706,000.00
- Revenue This Year
- CENX $6.79
- ARDX $15.74
- Revenue Next Year
- CENX $3.58
- ARDX $34.56
- P/E Ratio
- CENX $5.15
- ARDX N/A
- Revenue Growth
- CENX 4.75
- ARDX 127.33
- 52 Week Low
- CENX $11.40
- ARDX $3.62
- 52 Week High
- CENX $25.39
- ARDX $9.20
- Technical
- Relative Strength Index (RSI)
- CENX 44.66
- ARDX 32.18
- Support Level
- CENX $14.77
- ARDX $3.50
- Resistance Level
- CENX $17.57
- ARDX $5.65
- Average True Range (ATR)
- CENX 0.76
- ARDX 0.30
- MACD
- CENX 0.01
- ARDX -0.15
- Stochastic Oscillator
- CENX 39.50
- ARDX 5.59
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.